Results 341 to 350 of about 222,938 (359)

LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept

Cell Metabolism, 2022
exaly  

Glucose‐Responsive Composite Microneedle Patch for Hypoglycemia‐Triggered Delivery of Native Glucagon

Advanced Materials, 2019
amin GhavamiNejad, Adria Giacca, Xiao Yu Wu   +2 more
exaly  

A century of glucagon

Nature Reviews Endocrinology, 2023
openaire   +2 more sources

Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus

Circulation, 2019
Thomas A Zelniker, Itamar Raz, Erica L Goodrich   +2 more
exaly  

Glucagon

2007
openaire   +1 more source

Intussusception and Glucagon

Southern Medical Journal, 1985
openaire   +3 more sources

Nasal Glucagon

Hospital Pharmacy, 2019
Thomas J. Borden, Terri L. Levien, Danial E. Baker   +2 more
openaire   +2 more sources

Targeting the Incretin/Glucagon System With Triagonists to Treat Diabetes

Endocrine Reviews, 2018
Megan Capozzi, Richard D Dimarchi, Brian Finan   +2 more
exaly  

GLUCAGON AND THE HEART

The Lancet, 1970
openaire   +3 more sources

Glucagon, glucagon-like peptide and secretin

British Journal of Pharmacology, 2006
Alistair Mathie, S P H Alexander, John A. Peters   +2 more
openaire   +2 more sources